2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Egr1
|
ENSMUSG00000038418.7 | early growth response 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Egr1 | mm10_v2_chr18_+_34861200_34861215 | -0.56 | 5.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_+_36195968 | 3.43 |
ENSMUST00000115256.1
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chr7_-_45370559 | 2.87 |
ENSMUST00000003971.7
|
Lin7b
|
lin-7 homolog B (C. elegans) |
chr5_+_137030275 | 2.29 |
ENSMUST00000041543.8
|
Vgf
|
VGF nerve growth factor inducible |
chr3_-_89089955 | 2.16 |
ENSMUST00000166687.1
|
Rusc1
|
RUN and SH3 domain containing 1 |
chr6_-_4747157 | 2.14 |
ENSMUST00000090686.4
ENSMUST00000115579.1 ENSMUST00000115577.2 ENSMUST00000101677.3 ENSMUST00000004750.8 |
Sgce
|
sarcoglycan, epsilon |
chr5_+_137288273 | 2.10 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chrX_+_36195938 | 2.01 |
ENSMUST00000048067.3
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chrX_+_36195904 | 1.97 |
ENSMUST00000115258.2
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chrX_+_36195950 | 1.96 |
ENSMUST00000115257.1
|
Zcchc12
|
zinc finger, CCHC domain containing 12 |
chr2_-_94264713 | 1.90 |
ENSMUST00000129661.1
|
E530001K10Rik
|
RIKEN cDNA E530001K10 gene |
chr6_-_4747019 | 1.86 |
ENSMUST00000126151.1
ENSMUST00000133306.1 ENSMUST00000123907.1 |
Sgce
|
sarcoglycan, epsilon |
chrX_-_7574120 | 1.80 |
ENSMUST00000045924.7
ENSMUST00000115742.2 ENSMUST00000150787.1 |
Ppp1r3f
|
protein phosphatase 1, regulatory (inhibitor) subunit 3F |
chr2_+_157914618 | 1.70 |
ENSMUST00000109523.1
|
Vstm2l
|
V-set and transmembrane domain containing 2-like |
chr11_+_98348404 | 1.58 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr12_+_108334341 | 1.58 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chrX_+_7842056 | 1.54 |
ENSMUST00000115667.3
ENSMUST00000115668.3 ENSMUST00000115665.1 |
Otud5
|
OTU domain containing 5 |
chr4_+_43046014 | 1.52 |
ENSMUST00000180426.1
|
Gm26881
|
predicted gene, 26881 |
chr1_-_174921813 | 1.51 |
ENSMUST00000055294.3
|
Grem2
|
gremlin 2 homolog, cysteine knot superfamily (Xenopus laevis) |
chr2_+_119237531 | 1.45 |
ENSMUST00000110817.2
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr5_+_64970069 | 1.44 |
ENSMUST00000031080.8
|
Fam114a1
|
family with sequence similarity 114, member A1 |
chr16_-_20730544 | 1.43 |
ENSMUST00000076422.5
|
Thpo
|
thrombopoietin |
chr15_+_99591028 | 1.43 |
ENSMUST00000169082.1
|
Aqp5
|
aquaporin 5 |
chr6_+_28981490 | 1.42 |
ENSMUST00000164104.1
|
Gm3294
|
predicted gene 3294 |
chr4_-_43046196 | 1.36 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr2_+_93187574 | 1.36 |
ENSMUST00000090554.4
|
Trp53i11
|
transformation related protein 53 inducible protein 11 |
chr11_+_114851814 | 1.35 |
ENSMUST00000053361.5
ENSMUST00000021071.7 ENSMUST00000136785.1 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr6_+_4747306 | 1.34 |
ENSMUST00000175823.1
ENSMUST00000176204.1 ENSMUST00000166678.1 |
Peg10
|
paternally expressed 10 |
chr5_+_138995038 | 1.32 |
ENSMUST00000100518.2
|
6330403L08Rik
|
RIKEN cDNA 6330403L08 gene |
chr4_-_43045686 | 1.31 |
ENSMUST00000107956.1
ENSMUST00000107957.1 |
Fam214b
|
family with sequence similarity 214, member B |
chr11_+_85832551 | 1.28 |
ENSMUST00000000095.6
|
Tbx2
|
T-box 2 |
chr9_+_75410145 | 1.27 |
ENSMUST00000180533.1
ENSMUST00000180574.1 |
4933433G15Rik
|
RIKEN cDNA 4933433G15 gene |
chr2_+_119237351 | 1.26 |
ENSMUST00000028783.7
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr2_+_93187542 | 1.25 |
ENSMUST00000111266.1
ENSMUST00000150462.1 |
Trp53i11
|
transformation related protein 53 inducible protein 11 |
chr4_-_40722307 | 1.22 |
ENSMUST00000181475.1
|
Gm6297
|
predicted gene 6297 |
chr2_+_119237453 | 1.19 |
ENSMUST00000110816.1
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chrX_-_135009185 | 1.16 |
ENSMUST00000113185.2
ENSMUST00000064659.5 |
Zmat1
|
zinc finger, matrin type 1 |
chr12_-_119238794 | 1.15 |
ENSMUST00000026360.8
|
Itgb8
|
integrin beta 8 |
chrX_-_162159717 | 1.12 |
ENSMUST00000087085.3
|
Nhs
|
Nance-Horan syndrome (human) |
chr4_+_41760454 | 1.10 |
ENSMUST00000108040.1
|
Il11ra1
|
interleukin 11 receptor, alpha chain 1 |
chr3_+_28263205 | 1.07 |
ENSMUST00000159236.2
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr4_+_120161206 | 1.06 |
ENSMUST00000030384.4
|
Edn2
|
endothelin 2 |
chr2_-_94264745 | 1.02 |
ENSMUST00000134563.1
|
E530001K10Rik
|
RIKEN cDNA E530001K10 gene |
chr4_+_42949814 | 1.01 |
ENSMUST00000037872.3
ENSMUST00000098112.2 |
Dnajb5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr17_-_87282771 | 1.01 |
ENSMUST00000161759.1
|
4833418N02Rik
|
RIKEN cDNA 4833418N02 gene |
chr5_+_100039990 | 0.99 |
ENSMUST00000169390.1
ENSMUST00000031268.6 |
Enoph1
|
enolase-phosphatase 1 |
chr12_+_36157124 | 0.99 |
ENSMUST00000041640.3
|
Ankmy2
|
ankyrin repeat and MYND domain containing 2 |
chr17_-_87282793 | 0.97 |
ENSMUST00000146560.2
|
4833418N02Rik
|
RIKEN cDNA 4833418N02 gene |
chr8_+_84415348 | 0.97 |
ENSMUST00000121390.1
ENSMUST00000122053.1 |
Cacna1a
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
chr17_+_28523257 | 0.95 |
ENSMUST00000181029.1
ENSMUST00000095448.4 |
E230001N04Rik
|
RIKEN cDNA E230001N04 gene |
chr12_-_104865076 | 0.93 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr7_+_73740277 | 0.93 |
ENSMUST00000107456.2
|
Fam174b
|
family with sequence similarity 174, member B |
chr8_-_90908415 | 0.92 |
ENSMUST00000098517.1
|
Gm6658
|
predicted gene 6658 |
chr11_-_106160101 | 0.91 |
ENSMUST00000045923.3
|
Limd2
|
LIM domain containing 2 |
chr11_+_4186789 | 0.89 |
ENSMUST00000041042.6
ENSMUST00000180088.1 |
Tbc1d10a
|
TBC1 domain family, member 10a |
chr3_-_89093358 | 0.89 |
ENSMUST00000090929.5
ENSMUST00000052539.6 |
Rusc1
|
RUN and SH3 domain containing 1 |
chr5_-_138994935 | 0.88 |
ENSMUST00000046901.7
ENSMUST00000076095.7 |
Pdgfa
|
platelet derived growth factor, alpha |
chr7_+_27486910 | 0.88 |
ENSMUST00000008528.7
|
Sertad1
|
SERTA domain containing 1 |
chr11_+_117115195 | 0.87 |
ENSMUST00000103026.3
ENSMUST00000090433.5 |
Sec14l1
|
SEC14-like 1 (S. cerevisiae) |
chr11_+_117115133 | 0.87 |
ENSMUST00000021177.8
|
Sec14l1
|
SEC14-like 1 (S. cerevisiae) |
chr13_-_13393592 | 0.87 |
ENSMUST00000021738.8
|
Gpr137b
|
G protein-coupled receptor 137B |
chr15_-_76660108 | 0.86 |
ENSMUST00000066677.8
ENSMUST00000177359.1 |
Cyhr1
|
cysteine and histidine rich 1 |
chr9_+_21955747 | 0.85 |
ENSMUST00000053583.5
|
Swsap1
|
SWIM type zinc finger 7 associated protein 1 |
chr10_-_75932468 | 0.85 |
ENSMUST00000120281.1
ENSMUST00000000924.6 |
Mmp11
|
matrix metallopeptidase 11 |
chr4_-_126968124 | 0.84 |
ENSMUST00000106108.2
|
Zmym4
|
zinc finger, MYM-type 4 |
chr7_-_97332017 | 0.84 |
ENSMUST00000139582.2
|
Usp35
|
ubiquitin specific peptidase 35 |
chr17_-_10320229 | 0.83 |
ENSMUST00000053066.6
|
Qk
|
quaking |
chr16_+_20696175 | 0.83 |
ENSMUST00000128273.1
|
Fam131a
|
family with sequence similarity 131, member A |
chr11_+_114851507 | 0.82 |
ENSMUST00000177952.1
|
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr10_-_80139347 | 0.82 |
ENSMUST00000105369.1
|
Dos
|
downstream of Stk11 |
chr7_+_102267795 | 0.81 |
ENSMUST00000033289.4
|
Stim1
|
stromal interaction molecule 1 |
chr7_-_142659482 | 0.80 |
ENSMUST00000121128.1
|
Igf2
|
insulin-like growth factor 2 |
chr16_-_22439570 | 0.80 |
ENSMUST00000170393.1
|
Etv5
|
ets variant gene 5 |
chr4_-_151996113 | 0.80 |
ENSMUST00000055688.9
|
Phf13
|
PHD finger protein 13 |
chr4_-_127330799 | 0.78 |
ENSMUST00000046532.3
|
Gjb3
|
gap junction protein, beta 3 |
chr1_+_167001417 | 0.78 |
ENSMUST00000165874.1
|
Fam78b
|
family with sequence similarity 78, member B |
chr2_-_128967725 | 0.77 |
ENSMUST00000099385.2
|
Gm10762
|
predicted gene 10762 |
chr7_-_27333602 | 0.76 |
ENSMUST00000118583.1
ENSMUST00000118961.1 ENSMUST00000121175.1 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chrX_-_20920911 | 0.76 |
ENSMUST00000081893.6
ENSMUST00000115345.1 |
Syn1
|
synapsin I |
chr11_+_97799565 | 0.76 |
ENSMUST00000043843.5
|
Lasp1
|
LIM and SH3 protein 1 |
chr9_-_102354685 | 0.76 |
ENSMUST00000035129.7
ENSMUST00000085169.5 |
Ephb1
|
Eph receptor B1 |
chrX_+_49470450 | 0.76 |
ENSMUST00000114904.3
|
Arhgap36
|
Rho GTPase activating protein 36 |
chr7_-_27396542 | 0.75 |
ENSMUST00000108363.1
|
Sptbn4
|
spectrin beta, non-erythrocytic 4 |
chr11_+_115187481 | 0.75 |
ENSMUST00000100235.2
ENSMUST00000061450.6 |
Tmem104
|
transmembrane protein 104 |
chr10_-_81350389 | 0.74 |
ENSMUST00000020454.4
ENSMUST00000105324.2 ENSMUST00000154609.2 ENSMUST00000105323.1 |
Hmg20b
|
high mobility group 20B |
chr5_+_150952607 | 0.73 |
ENSMUST00000078856.6
|
Kl
|
klotho |
chr5_+_30588078 | 0.73 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr3_+_96670131 | 0.73 |
ENSMUST00000048427.5
|
Ankrd35
|
ankyrin repeat domain 35 |
chr16_-_94370994 | 0.73 |
ENSMUST00000113914.1
ENSMUST00000113905.1 |
Pigp
|
phosphatidylinositol glycan anchor biosynthesis, class P |
chr2_+_156840966 | 0.72 |
ENSMUST00000109564.1
|
Tgif2
|
TGFB-induced factor homeobox 2 |
chrX_+_6047453 | 0.71 |
ENSMUST00000103007.3
|
Nudt11
|
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr3_-_84479418 | 0.70 |
ENSMUST00000091002.1
|
Fhdc1
|
FH2 domain containing 1 |
chr10_+_67535465 | 0.70 |
ENSMUST00000145754.1
|
Egr2
|
early growth response 2 |
chr10_+_83722865 | 0.70 |
ENSMUST00000150459.1
|
1500009L16Rik
|
RIKEN cDNA 1500009L16 gene |
chr11_-_106788486 | 0.69 |
ENSMUST00000021062.5
|
Ddx5
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 |
chr18_-_37935378 | 0.69 |
ENSMUST00000025337.7
|
Diap1
|
diaphanous homolog 1 (Drosophila) |
chr11_+_70540260 | 0.68 |
ENSMUST00000018429.5
ENSMUST00000108557.3 ENSMUST00000108556.1 |
Pld2
|
phospholipase D2 |
chr5_+_137553517 | 0.68 |
ENSMUST00000136088.1
ENSMUST00000139395.1 ENSMUST00000136565.1 ENSMUST00000149292.1 ENSMUST00000125489.1 |
Actl6b
|
actin-like 6B |
chr5_+_92137896 | 0.68 |
ENSMUST00000031355.6
|
Uso1
|
USO1 vesicle docking factor |
chr5_-_137611372 | 0.68 |
ENSMUST00000054564.6
|
Pcolce
|
procollagen C-endopeptidase enhancer protein |
chr16_+_81200697 | 0.68 |
ENSMUST00000067602.3
ENSMUST00000037785.7 |
Ncam2
|
neural cell adhesion molecule 2 |
chr15_+_7129557 | 0.67 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chrX_-_47892502 | 0.67 |
ENSMUST00000077569.4
ENSMUST00000101616.2 ENSMUST00000088973.4 |
Smarca1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr10_-_81350305 | 0.67 |
ENSMUST00000167481.1
|
Hmg20b
|
high mobility group 20B |
chr10_-_81350191 | 0.66 |
ENSMUST00000122993.1
|
Hmg20b
|
high mobility group 20B |
chr17_+_35979851 | 0.66 |
ENSMUST00000087200.3
|
Gnl1
|
guanine nucleotide binding protein-like 1 |
chr11_-_5261558 | 0.66 |
ENSMUST00000020662.8
|
Kremen1
|
kringle containing transmembrane protein 1 |
chr11_+_80300866 | 0.66 |
ENSMUST00000017836.7
|
Rhbdl3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr14_+_61599493 | 0.66 |
ENSMUST00000039562.6
|
Trim13
|
tripartite motif-containing 13 |
chr4_+_128883549 | 0.65 |
ENSMUST00000035667.8
|
Trim62
|
tripartite motif-containing 62 |
chr8_+_4248188 | 0.65 |
ENSMUST00000110993.1
|
Gm14378
|
predicted gene 14378 |
chr3_-_57847478 | 0.65 |
ENSMUST00000120289.1
ENSMUST00000066882.8 |
Pfn2
|
profilin 2 |
chr9_-_75409951 | 0.65 |
ENSMUST00000049355.10
|
Mapk6
|
mitogen-activated protein kinase 6 |
chr6_+_88724462 | 0.64 |
ENSMUST00000113582.1
|
Mgll
|
monoglyceride lipase |
chr5_-_5380185 | 0.64 |
ENSMUST00000030763.6
|
Cdk14
|
cyclin-dependent kinase 14 |
chr18_-_37935429 | 0.64 |
ENSMUST00000115634.1
|
Diap1
|
diaphanous homolog 1 (Drosophila) |
chr2_-_168741898 | 0.64 |
ENSMUST00000109176.1
ENSMUST00000178504.1 |
Atp9a
|
ATPase, class II, type 9A |
chr4_+_86748526 | 0.64 |
ENSMUST00000082026.7
ENSMUST00000045512.8 |
Dennd4c
|
DENN/MADD domain containing 4C |
chr11_-_51263042 | 0.63 |
ENSMUST00000054226.2
|
BC049762
|
cDNA sequence BC049762 |
chr11_-_89302545 | 0.62 |
ENSMUST00000061728.3
|
Nog
|
noggin |
chr19_-_4615453 | 0.62 |
ENSMUST00000053597.2
|
Lrfn4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr4_-_114908892 | 0.62 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr5_-_31291026 | 0.61 |
ENSMUST00000041565.7
|
Ift172
|
intraflagellar transport 172 |
chr1_+_36511867 | 0.61 |
ENSMUST00000001166.7
ENSMUST00000097776.3 |
Cnnm3
|
cyclin M3 |
chr5_-_137611429 | 0.61 |
ENSMUST00000031731.7
|
Pcolce
|
procollagen C-endopeptidase enhancer protein |
chr11_-_51262940 | 0.61 |
ENSMUST00000065950.3
|
BC049762
|
cDNA sequence BC049762 |
chr9_-_119093468 | 0.60 |
ENSMUST00000010804.2
|
Plcd1
|
phospholipase C, delta 1 |
chr5_-_22344690 | 0.60 |
ENSMUST00000062372.7
ENSMUST00000161356.1 |
Reln
|
reelin |
chr13_-_43480973 | 0.60 |
ENSMUST00000144326.2
|
Ranbp9
|
RAN binding protein 9 |
chr15_+_87625214 | 0.60 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chrX_+_49470555 | 0.59 |
ENSMUST00000042444.6
|
Arhgap36
|
Rho GTPase activating protein 36 |
chr18_-_37935403 | 0.58 |
ENSMUST00000080033.6
ENSMUST00000115631.1 |
Diap1
|
diaphanous homolog 1 (Drosophila) |
chr19_+_45363734 | 0.58 |
ENSMUST00000065601.5
ENSMUST00000111936.2 |
Btrc
|
beta-transducin repeat containing protein |
chr11_-_86993682 | 0.57 |
ENSMUST00000018571.4
|
Ypel2
|
yippee-like 2 (Drosophila) |
chr2_+_78869009 | 0.57 |
ENSMUST00000028398.7
|
Ube2e3
|
ubiquitin-conjugating enzyme E2E 3 |
chr17_-_35979679 | 0.57 |
ENSMUST00000173724.1
ENSMUST00000172900.1 ENSMUST00000174849.1 |
Prr3
|
proline-rich polypeptide 3 |
chr11_+_103116228 | 0.56 |
ENSMUST00000053063.5
|
Hexim1
|
hexamethylene bis-acetamide inducible 1 |
chr11_+_97799772 | 0.56 |
ENSMUST00000129558.1
|
Lasp1
|
LIM and SH3 protein 1 |
chr13_-_48870885 | 0.56 |
ENSMUST00000035540.7
|
Phf2
|
PHD finger protein 2 |
chr9_-_119578981 | 0.56 |
ENSMUST00000117911.1
ENSMUST00000120420.1 |
Scn5a
|
sodium channel, voltage-gated, type V, alpha |
chr2_+_156008045 | 0.56 |
ENSMUST00000006035.6
|
Ergic3
|
ERGIC and golgi 3 |
chr4_+_43669610 | 0.56 |
ENSMUST00000107866.1
|
Tmem8b
|
transmembrane protein 8B |
chrX_-_75416562 | 0.55 |
ENSMUST00000033543.7
ENSMUST00000149863.2 ENSMUST00000114081.1 |
Mtcp1
Mtcp1
|
mature T cell proliferation 1 mature T cell proliferation 1 |
chr4_+_143349757 | 0.55 |
ENSMUST00000052458.2
|
Lrrc38
|
leucine rich repeat containing 38 |
chr2_+_156008088 | 0.55 |
ENSMUST00000088650.4
|
Ergic3
|
ERGIC and golgi 3 |
chr19_+_42147373 | 0.55 |
ENSMUST00000061111.9
|
Marveld1
|
MARVEL (membrane-associating) domain containing 1 |
chr8_+_47675362 | 0.55 |
ENSMUST00000098781.2
|
AA386476
|
expressed sequence AA386476 |
chr11_-_69880971 | 0.54 |
ENSMUST00000050555.3
|
Kctd11
|
potassium channel tetramerisation domain containing 11 |
chr11_-_101785252 | 0.53 |
ENSMUST00000164750.1
ENSMUST00000107176.1 ENSMUST00000017868.6 |
Etv4
|
ets variant gene 4 (E1A enhancer binding protein, E1AF) |
chr7_-_19749464 | 0.53 |
ENSMUST00000075447.7
ENSMUST00000108450.3 |
Pvrl2
|
poliovirus receptor-related 2 |
chr14_-_30626196 | 0.53 |
ENSMUST00000112210.3
ENSMUST00000112211.2 ENSMUST00000112208.1 |
Prkcd
|
protein kinase C, delta |
chr6_+_29526625 | 0.53 |
ENSMUST00000004392.5
|
Irf5
|
interferon regulatory factor 5 |
chr8_+_69088646 | 0.52 |
ENSMUST00000006435.7
|
Atp6v1b2
|
ATPase, H+ transporting, lysosomal V1 subunit B2 |
chr2_+_168081004 | 0.52 |
ENSMUST00000052125.6
|
Pard6b
|
par-6 (partitioning defective 6) homolog beta (C. elegans) |
chr3_+_106721672 | 0.52 |
ENSMUST00000098750.2
ENSMUST00000130105.1 |
Lrif1
|
ligand dependent nuclear receptor interacting factor 1 |
chr11_-_97884122 | 0.52 |
ENSMUST00000093939.3
|
Fbxo47
|
F-box protein 47 |
chr9_+_107569112 | 0.52 |
ENSMUST00000010191.7
|
Hyal2
|
hyaluronoglucosaminidase 2 |
chr11_+_119022962 | 0.52 |
ENSMUST00000026662.7
|
Cbx2
|
chromobox 2 |
chr3_+_28263563 | 0.52 |
ENSMUST00000160307.2
ENSMUST00000159680.2 ENSMUST00000160518.1 ENSMUST00000162485.1 ENSMUST00000159308.1 ENSMUST00000162777.1 ENSMUST00000161964.1 |
Tnik
|
TRAF2 and NCK interacting kinase |
chr7_-_45366714 | 0.51 |
ENSMUST00000107779.1
|
Ppfia3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr7_-_109865586 | 0.51 |
ENSMUST00000007423.5
ENSMUST00000106728.2 ENSMUST00000106729.1 |
Scube2
|
signal peptide, CUB domain, EGF-like 2 |
chr1_+_91801453 | 0.51 |
ENSMUST00000007949.3
|
Twist2
|
twist basic helix-loop-helix transcription factor 2 |
chr17_-_24533709 | 0.51 |
ENSMUST00000061764.7
|
Rab26
|
RAB26, member RAS oncogene family |
chr3_+_106721893 | 0.51 |
ENSMUST00000106736.2
ENSMUST00000154973.1 ENSMUST00000131330.1 ENSMUST00000150513.1 |
Lrif1
|
ligand dependent nuclear receptor interacting factor 1 |
chr6_-_126645784 | 0.51 |
ENSMUST00000055168.3
|
Kcna1
|
potassium voltage-gated channel, shaker-related subfamily, member 1 |
chr19_-_5085483 | 0.50 |
ENSMUST00000140389.1
ENSMUST00000151413.1 ENSMUST00000077066.7 |
Tmem151a
|
transmembrane protein 151A |
chr2_-_130840091 | 0.50 |
ENSMUST00000044766.8
ENSMUST00000138990.1 ENSMUST00000120316.1 ENSMUST00000110243.1 |
4930402H24Rik
|
RIKEN cDNA 4930402H24 gene |
chr7_+_97332311 | 0.50 |
ENSMUST00000054107.5
|
Kctd21
|
potassium channel tetramerisation domain containing 21 |
chr10_-_80742211 | 0.50 |
ENSMUST00000020420.7
|
Ap3d1
|
adaptor-related protein complex 3, delta 1 subunit |
chr17_+_26715644 | 0.50 |
ENSMUST00000062519.7
ENSMUST00000144221.1 ENSMUST00000142539.1 ENSMUST00000151681.1 |
Crebrf
|
CREB3 regulatory factor |
chr2_+_143546144 | 0.50 |
ENSMUST00000028905.9
|
Pcsk2
|
proprotein convertase subtilisin/kexin type 2 |
chr11_+_69088490 | 0.49 |
ENSMUST00000021273.6
ENSMUST00000117780.1 |
Vamp2
|
vesicle-associated membrane protein 2 |
chr7_+_99535652 | 0.49 |
ENSMUST00000032995.8
ENSMUST00000162404.1 |
Arrb1
|
arrestin, beta 1 |
chr7_-_81454751 | 0.48 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr4_+_137468767 | 0.48 |
ENSMUST00000030547.8
ENSMUST00000171332.1 |
Hspg2
|
perlecan (heparan sulfate proteoglycan 2) |
chr8_-_122678072 | 0.48 |
ENSMUST00000006525.7
ENSMUST00000064674.6 |
Cbfa2t3
|
core-binding factor, runt domain, alpha subunit 2, translocated to, 3 (human) |
chr19_+_6363671 | 0.48 |
ENSMUST00000131252.1
|
Sf1
|
splicing factor 1 |
chr1_+_96872221 | 0.48 |
ENSMUST00000181489.1
|
Gm5101
|
predicted gene 5101 |
chr10_+_79854618 | 0.47 |
ENSMUST00000165704.1
|
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr11_-_103954015 | 0.47 |
ENSMUST00000103075.4
|
Nsf
|
N-ethylmaleimide sensitive fusion protein |
chr3_+_108186332 | 0.47 |
ENSMUST00000050909.6
ENSMUST00000106659.2 ENSMUST00000106656.1 ENSMUST00000106661.2 |
Amigo1
|
adhesion molecule with Ig like domain 1 |
chr6_+_134830145 | 0.47 |
ENSMUST00000046303.5
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr9_+_21165714 | 0.46 |
ENSMUST00000039413.8
|
Pde4a
|
phosphodiesterase 4A, cAMP specific |
chr1_-_191397026 | 0.46 |
ENSMUST00000067976.3
|
Ppp2r5a
|
protein phosphatase 2, regulatory subunit B (B56), alpha isoform |
chr11_-_106788845 | 0.46 |
ENSMUST00000123339.1
|
Ddx5
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 |
chr10_+_79854658 | 0.45 |
ENSMUST00000171599.1
ENSMUST00000095457.4 |
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr13_+_21735055 | 0.45 |
ENSMUST00000087714.4
|
Hist1h4j
|
histone cluster 1, H4j |
chr14_-_60177482 | 0.45 |
ENSMUST00000140924.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr5_+_145084100 | 0.45 |
ENSMUST00000124379.1
|
Arpc1a
|
actin related protein 2/3 complex, subunit 1A |
chr17_+_8525434 | 0.45 |
ENSMUST00000115722.1
|
Pde10a
|
phosphodiesterase 10A |
chr19_+_42255704 | 0.44 |
ENSMUST00000087123.5
|
Golga7b
|
golgi autoantigen, golgin subfamily a, 7B |
chr19_-_4397052 | 0.44 |
ENSMUST00000075856.4
|
Kdm2a
|
lysine (K)-specific demethylase 2A |
chr17_+_37046555 | 0.44 |
ENSMUST00000172789.1
|
Gabbr1
|
gamma-aminobutyric acid (GABA) B receptor, 1 |
chr11_+_88068242 | 0.44 |
ENSMUST00000018521.4
|
Vezf1
|
vascular endothelial zinc finger 1 |
chr10_-_116473875 | 0.44 |
ENSMUST00000068233.4
|
Kcnmb4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
chr6_+_72097561 | 0.44 |
ENSMUST00000069994.4
ENSMUST00000114112.1 |
St3gal5
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
chr11_-_115367667 | 0.44 |
ENSMUST00000123428.1
ENSMUST00000044152.6 ENSMUST00000106542.2 |
Hid1
|
HID1 domain containing |
chr9_+_59750876 | 0.44 |
ENSMUST00000136740.1
ENSMUST00000135298.1 ENSMUST00000128341.1 |
Myo9a
|
myosin IXa |
chr16_-_10543028 | 0.43 |
ENSMUST00000184863.1
ENSMUST00000038281.5 |
Dexi
|
dexamethasone-induced transcript |
chr7_+_3645267 | 0.43 |
ENSMUST00000038913.9
|
Cnot3
|
CCR4-NOT transcription complex, subunit 3 |
chr11_-_115187827 | 0.43 |
ENSMUST00000103041.1
|
Nat9
|
N-acetyltransferase 9 (GCN5-related, putative) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 9.4 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.7 | 2.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.6 | 2.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.7 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.4 | 1.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.4 | 2.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.4 | 1.6 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 1.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 1.0 | GO:0050883 | regulation of sulfur amino acid metabolic process(GO:0031335) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.3 | 0.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.3 | 1.7 | GO:0039536 | choline transport(GO:0015871) negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.1 | GO:0060584 | ovarian follicle rupture(GO:0001543) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 1.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.0 | GO:0043102 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.2 | 0.9 | GO:0021594 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.2 | 4.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 2.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.6 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.6 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.2 | 1.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 0.5 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.5 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.2 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.5 | GO:0072720 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.2 | 2.3 | GO:0043084 | penile erection(GO:0043084) |
0.2 | 1.0 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.6 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 1.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 2.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.8 | GO:0021631 | skeletal muscle satellite cell activation(GO:0014719) skeletal muscle satellite cell differentiation(GO:0014816) optic nerve morphogenesis(GO:0021631) |
0.1 | 0.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.4 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.5 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 0.7 | GO:1901906 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.1 | 0.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.2 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.1 | 0.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 0.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 1.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.5 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.1 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 1.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.5 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 0.2 | GO:2001076 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.5 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.1 | 1.1 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.2 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 0.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.5 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 1.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.3 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.1 | 0.4 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.2 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.1 | 0.4 | GO:2000320 | negative regulation of T cell cytokine production(GO:0002725) negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 1.4 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.4 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 1.2 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.1 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.1 | 0.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 1.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.0 | 0.1 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.0 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.3 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
0.0 | 0.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.3 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.0 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.5 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.6 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.2 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.0 | 0.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.0 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.4 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.0 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.0 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.0 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.1 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.0 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.0 | 1.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.2 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0032532 | regulation of microvillus organization(GO:0032530) regulation of microvillus length(GO:0032532) |
0.0 | 0.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.8 | GO:0090662 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.6 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.6 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.1 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0035553 | oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.0 | 0.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.1 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.4 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.5 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.6 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 1.1 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.0 | 0.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.9 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.0 | 0.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.6 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.2 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 1.9 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.4 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.0 | 0.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.7 | GO:0035272 | exocrine system development(GO:0035272) |
0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.7 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.0 | 1.0 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.5 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.5 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.3 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.6 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
0.0 | 0.5 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.0 | 0.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 4.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 2.1 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.4 | 2.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.3 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 0.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 0.5 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.1 | 0.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 0.8 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 2.6 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.3 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 0.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.1 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.9 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.0 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.4 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.7 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 2.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 1.2 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 0.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 8.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 2.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.7 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 1.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.4 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0005118 | sevenless binding(GO:0005118) |
0.7 | 0.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.6 | 1.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 1.6 | GO:0031752 | D3 dopamine receptor binding(GO:0031750) D5 dopamine receptor binding(GO:0031752) |
0.5 | 2.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 2.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 1.3 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.4 | 1.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.3 | 8.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.3 | 1.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 1.1 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.3 | 2.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 1.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.6 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.5 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.2 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 0.5 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.1 | 1.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.5 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.4 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.1 | 1.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.1 | 0.7 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 0.5 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.1 | 0.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 1.4 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.1 | 2.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.2 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 1.0 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) tumor necrosis factor binding(GO:0043120) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 1.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 1.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.3 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 1.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.4 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 1.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.1 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.8 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 1.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.0 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 9.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 2.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 1.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 2.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 2.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 1.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.7 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
0.0 | 1.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.2 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 1.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |